LRMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Larimar Therapeutics Inc (LRMR) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators suggest a bearish trend, options data reflects a bearish sentiment, and there are no significant positive catalysts or news to support an immediate buy decision. Additionally, the company's financials show significant losses, and there are no recent analyst ratings or upgrades to provide confidence in the stock's potential upside.
The technical indicators for LRMR show a bearish trend. The MACD histogram is negative and expanding downward, the RSI is neutral at 35.957, and the moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 3.36, with key support at 3.127 and resistance at 3.593.
NULL identified. There is no recent news, no significant insider or hedge fund activity, and no recent congress trading data. The stock has a 60% chance of a 9.63% increase in the next month, but this is not a strong enough catalyst for a long-term investment.
The MACD and moving averages indicate a bearish trend, and options data reflects bearish sentiment. Additionally, there are no recent analyst upgrades or positive news to support the stock.
In Q3 2025, Larimar Therapeutics reported a net income of -$47.71M, which represents a 207.84% YoY increase in losses. EPS improved to -0.61 (up 154.17% YoY), but the company has no revenue or gross margin, indicating a lack of operational profitability.
No recent analyst ratings or price target changes were provided. There is no Wall Street consensus on the stock's outlook.
